Netherlands· NL-89fc564ae049
Metvix 160 mg/g crème
A methyl aminolevulinate product containing methylaminolevulinaat hydrochloride, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Methyl aminolevulinate is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XD03 (methyl aminolevulinate), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Methyl aminolevulinate · ATC L01XD03
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- METHYLAMINOLEVULINAAT HYDROCHLORIDE
- Manufacturer
- Euro Registratie Collectief B.V.
- Country
- Netherlands (NL)
- ATC code
- L01XD03
- ATC class
- Methyl aminolevulinate
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id131736//31130
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01XD03
Methyl aminolevulinate, as other registers publish it.
- United StatesKRX Aesthetics PD-13 TherapyBY KIN AESTHETICS LLC
- United StatesKRX Aesthetics PD-13 TherapyKRX RESOURCES SDN. BHD.
- FinlandLuxeraGalderma Nordic AB
- GermanyLuxermGalderma Laboratorium Gmbh
- IcelandMetvixGalderma Nordic AB*
- NorwayMetvixGalderma Nordic AB
- FinlandMetvix2care4 ApS
- FinlandMetvixParanova Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c86993a6-886d-4792-8655-677c5a3c1bb2 GET /v1/drugs/c86993a6-886d-4792-8655-677c5a3c1bb2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Crème",
"route": "Cutaan gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h31130_smpc.pdf",
"strength": null,
"atc_label": "Methyl Aminolevulinate",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131736",
"excipients": [
"AMANDELOLIE",
"ARACHIDEOLIE",
"CETOSTEARYLALCOHOL",
"CHOLESTEROL",
"DINATRIUMEDETAAT 2-WATER",
"GLYCEROL (E 422)",
"GLYCERYLMONOSTEARAAT, ZELF-EMULGEREND",
"ISOPROPYLMYRISTAAT",
"MACROGOLSTEARAAT, TYPE I",
"METHYLPARAHYDROXYBENZOAAT (E 218)",
"OLEYLALCOHOL",
"PARAFFINE, ZACHT (E 905)",
"PROPYLPARAHYDROXYBENZOAAT",
"WATER, GEZUIVERD"
],
"substances": [
"METHYLAMINOLEVULINAAT HYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131736.pdf",
"authorised_at": "2023/08/14",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "131736//31130",
"additional_monitoring": "N"
}See everything about methyl aminolevulinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.